https://www.taxtmi.com/news?id=63566 Call for abstracts opened for the 2026 ASCO Breakthrough meeting in Singapore, with submissions due 24 February 2026 (11:59 PM ET). The meeting runs 25-27 June 2026; accepted abstracts will be published in the Journal of Clinical Oncology supplement and Trials in Progress abstracts will be accepted. Research tracks include AI and digital technology, disease-specific topics, developmental therapeutics, antibody drug conjugates and devices. Professionals in low-and-middle-income countries may apply for fee waivers at submission; registrations open December 2025. en-us Thu, 04 Dec 2025 11:16:02 +0530 Thu, 04 Dec 2025 11:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=63566 Call for abstracts opened for the 2026 ASCO Breakthrough meeting in Singapore, with submissions due 24 February 2026 (11:59 PM ET). The meeting runs 25-27 June 2026; accepted abstracts will be published in the Journal of Clinical Oncology supplement and Trials in Progress abstracts will be accepted. Research tracks include AI and digital technology, disease-specific topics, developmental therapeutics, antibody drug conjugates and devices. Professionals in low-and-middle-income countries may apply for fee waivers at submission; registrations open December 2025. News - Thu, 04 Dec 2025 11:16:02 +0530 https://www.taxtmi.com/news?id=63566